Abstract:Rapidly improving methods for glycoproteomics have enabled increasingly large-scale analyses of complex glycopeptide samples, but annotating the resulting mass spectrometry data with high confidence remains a major bottleneck. We recently introduced a fast and sensitive glycoproteomics search method in our MSFragger search engine, which reports glycopeptides as a combination of a peptide sequence and the mass of the attached glycan. In samples with complex glycosylation patterns, converting this mass to a spec… Show more
“…However, this does not mean that ion mobility added information will not be useful in other scenarios. IM may improve the resolution of peptidoforms with isobaric modifications (e.g., in glycopeptide identification workflows [69]) or assist with PTM site localization [70, 71]. The minimal strength of IM features observed in this work may also be due to the limitations of a linear SVM model in Percolator.…”
Peptide identification in liquid chromatography-tandem mass spectrometry (LC-MS/MS) experiments relies on computational algorithms for matching acquired MS/MS spectra against sequences of candidate peptides using database search tools, such as MSFragger. Here, we present a new tool, MSBooster, for rescoring peptide-to-spectrum matches using additional features incorporating deep learning-based predictions of peptide properties, such as LC retention time, ion mobility, and MS/MS spectra. We demonstrate the utility of MSBooster, in tandem with MSFragger and Percolator, in several different workflows, including nonspecific searches (immunopeptidomics), direct identification of peptides from data independent acquisition data, single-cell proteomics, and data generated on an ion mobility separation-enabled timsTOF MS platform. MSBooster is fast, robust, and fully integrated into the widely used FragPipe computational platform.
“…However, this does not mean that ion mobility added information will not be useful in other scenarios. IM may improve the resolution of peptidoforms with isobaric modifications (e.g., in glycopeptide identification workflows [69]) or assist with PTM site localization [70, 71]. The minimal strength of IM features observed in this work may also be due to the limitations of a linear SVM model in Percolator.…”
Peptide identification in liquid chromatography-tandem mass spectrometry (LC-MS/MS) experiments relies on computational algorithms for matching acquired MS/MS spectra against sequences of candidate peptides using database search tools, such as MSFragger. Here, we present a new tool, MSBooster, for rescoring peptide-to-spectrum matches using additional features incorporating deep learning-based predictions of peptide properties, such as LC retention time, ion mobility, and MS/MS spectra. We demonstrate the utility of MSBooster, in tandem with MSFragger and Percolator, in several different workflows, including nonspecific searches (immunopeptidomics), direct identification of peptides from data independent acquisition data, single-cell proteomics, and data generated on an ion mobility separation-enabled timsTOF MS platform. MSBooster is fast, robust, and fully integrated into the widely used FragPipe computational platform.
“…2B-E). Glycan peptide spectral matches (GlycoPSMs) were obtained by analysis with MSFragger in glyco mode using the FragPipe analysis suite (Kong et al, 2017;Polasky et al, 2022Polasky et al, , 2020 and filtered by excluding those glycoPSMs with a calculated false discovery rate cut-off (Q-value) of < 0.025. A total of over 2,500 unique glycopeptides from over 550 glycoproteins was identified by this method (Fig.…”
Section: Glycoproteomics At the Synapsementioning
confidence: 99%
“…For glycoproteomics experiments, runs were grouped by sample type (SV, SV with enrichment, or synaptosomes with enrichment) prior to analysis. The same mouse protein database was used and spectra were searched with MSFragger (v.3.4) using glyco mode (Polasky et al, 2022(Polasky et al, , 2020 with the following settings: precursor mass tolerance, ± 20 ppm; fragment mass tolerance, ± 20 ppm, mass calibration and parameter optimization enabled; isotope error, 0/1/2; enzymatic cleavage, strict trypsin with up to 2 missed cleavages; peptide length, 7-50; peptide mass range, 400-5000 Da. Methionine oxidation and N-terminal acetylation were allowed as variable modifications and cysteine carbamidomethylation included as a fixed modification.…”
At neuronal synapses, synaptic vesicles (SVs) require glycoproteins for normal trafficking, and N-linked glycosylation is required for delivery of the major SV glycoproteins synaptophysin and SV2A to SVs. The molecular compositions of SV N-glycans, which may drive important neurobiological processes, are largely unknown. In this study, we combined organelle isolation techniques, fluorescence detection of N-glycans, and high-resolution mass spectrometry to characterize N-glycosylation at synapses and SVs from mouse brain. Detecting over 2,500 unique glycopeptides from over 550 glycoproteins, we found that abundant SV proteins harbor N-glycans with fucose on their complex antennae, and we identify a highly fucosylated N-glycan enriched in SVs as compared to synaptosomes. Antennary fucosylation was also characteristic of plasma membrane proteins and cell adhesion molecules with established roles in synaptic function and development. Our results represent the first defined N-glycoproteome of a neuronal organelle and raise new questions in the glycobiology of synaptic pruning and neuroinflammation.
“…1b ). We further filtered glyco-PSMs by glycan q-value (q ≤ 0.05) to remove glycopeptides lacking sufficient evidence supporting the glycan composition assignment 29 by PTM-Shepherd 30 . With this improved filtering method, the proportion of PSMs corresponding to known glycosites increased to 96%, and the proportion of identified glycosites corresponding to known glycoproteins increased to 95%, with 79% of sites previously identified in other glycoproteomic analyses (Supplementary Fig.…”
Section: Resultsmentioning
confidence: 99%
“…CC-BY-ND 4.0 International license perpetuity. It is made available under a preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in The copyright holder for this this version posted December 8, 2022. ; https://doi.org/10.1101/2022.12.05.519200 doi: bioRxiv preprint by glycan q-value (q ≤ 0.05) to remove glycopeptides lacking sufficient evidence supporting the glycan composition assignment 29 by PTM-Shepherd 30 . With this improved filtering method, the proportion of PSMs corresponding to known glycosites increased to 96%, and the proportion of identified glycosites corresponding to known glycoproteins increased to 95%, with 79% of sites previously identified in other glycoproteomic analyses (Supplementary Fig.…”
MHC-associated peptides (MAPs) bearing post-translational modifications (PTMs) have raised intriguing questions regarding their attractiveness for targeted therapies. Here, we developed a novel computational glyco-immunopeptidomics workflow that integrates the ultrafast glycopeptide search of MSFragger with a glycopeptide-focused false discovery rate (FDR) control. We performed a harmonized analysis of 8 large-scale publicly available studies and found that glycosylated MAPs are predominantly presented by the MHC class II. We created HLA-Glyco, a resource containing over 3,400 human leukocyte antigen (HLA) class II N-glycopeptides from 1,049 distinct protein glycosylation sites. Our comprehensive resource reveals high levels of truncated glycans, conserved HLA-binding cores, and differences in glycosylation positional specificity between classical HLA class II allele groups. To support the nascent field of glyco-immunopeptidomics, we include the optimized workflow in the FragPipe suite and provide HLA-Glyco as a free web resource.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.